Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Ocd received complaints of falsely elevated patient results using heparin plasma sample types for vitros chemistry products dxgn slides. internal testing confirmed these reports of falsely elevated patient results using heparin plasma samples only. serum samples obtained from the same patients did not exhibit elevated results. as a result of this investigation heparin plasma is being removed as a recommended sample type from the vitros digoxin slides instructions for use (ifu).